Inositec
ExitedInositec is a biotech company that develops a treatment for soft tissue calcification disorders.
Inositec is tracked in the Tech.eu funding database. Based in Zurich, Switzerland; active in Healthtech. Acquired by Vifor Pharma in 2021. Data as of Nov 2026.
Zurich, Switzerlandinositec.com ↗
Total raised
—
no tracked rounds
Funding rounds
0
Investors
0
distinct backers
Active since
—
Funding rounds
0 roundsNo funding rounds recorded.
Exit
Type
acquisition
Date
Nov 2021
Value
€19M
Acquiror
Vifor Pharma (Switzerland)
Related news
- Vifor Pharma to acquire Inositecstartupticker.ch · 2021-11
Similar companies
same sector, similar sizeGlobal coverage: FundingData